141 results
Page 2 of 8
424B5
fq5uob8 vnoe7agln
9 Mar 22
Prospectus supplement for primary offering
4:20pm
424B5
9dep0 gnpdmt
8 Mar 22
Prospectus supplement for primary offering
7:41am
S-3ASR
t8n5flfq1dbfa798fi6v
3 Sep 21
Automatic shelf registration
4:20pm
S-3ASR
EX-4.12
5mi4zehwh9y4x 9aen
3 Sep 21
Automatic shelf registration
4:20pm
8-K
EX-99.1
led4c6i3
19 May 21
Departure of Directors or Certain Officers
12:00am
8-K
EX-1.1
1fyok
12 Feb 21
Travere Therapeutics Announces Proposed Public Offering of Common Stock
4:46pm
424B5
iv8aa k9rnu2ui63z
12 Feb 21
Prospectus supplement for primary offering
4:43pm
424B5
alc3hpj2
10 Feb 21
Prospectus supplement for primary offering
4:40pm
8-K
EX-2.1
eiiqv67cs4gr0v8fm2
18 Nov 20
Completion of Acquisition or Disposition of Assets
5:18pm
8-K
EX-3.1
bcrk1qv
16 Nov 20
Amendments to Articles of Incorporation or Bylaws
4:04pm
8-K
EX-1.1
fh9myce6 ffl
9 Jun 20
Retrophin Announces Proposed Public Offering of Common Stock
4:08pm
424B5
ypd wqqdb
9 Jun 20
Prospectus supplement for primary offering
4:06pm
424B5
9s1nd4l
8 Jun 20
Prospectus supplement for primary offering
4:13pm